Trust Chemists and Druggists Private Limited has raised equity
Diciembre 2023 — Trust Chemists and Druggists Private Limited has successfully completed an equity raise.
Founded in 2003, Trust Chemists and Druggists operates one of the largest hospital pharmacy chains in India. Specializing in managing in-hospital pharmacies, the company operates 47 in-hospital stores and 14 standalone stores across Karnataka, Tamil Nadu and Andhra Pradesh. It offers a one-stop shop for all medicines and wellness needs.
Nuestro papel en la transacción
Oaklins’ team in India provided strategic and financial advisory services throughout this transaction. The team onboarded an investor, a family office, adding strategic value and contributing to financial growth. This investor acquired a 26% fully diluted stake in the investee.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate
Terhills Resort, a premium resort in Belgium combining luxury and nature located near Hoge Kempen National Park and operated by Center Parcs, has been sold by venture capitalist LRM to TwentyTwo Real Estate, an independent real estate investor and operator. Both the real estate and the operations were included in the transaction, and Center Parcs is staying on board as an operational partner.
Conozca másOEP Danzig BidCo has completed a mandatory tender offer for the shares of Digital Value
OEP Danzig BidCo S.p.A. has completed a mandatory tender offer for the shares of Digital Value S.p.A.
Conozca másBolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company
Bolster Investment Partners has partnered with Royal Taste Company, a leading Dutch custom signature coffee platform offering end-to-end sourcing, blending, roasting, packaging and delivery services. The partnership marks an important next step in Royal Taste Company’s growth trajectory, focused on further geographical expansion, commercial development and selective strategic acquisitions.
Conozca más